Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Researchers at University of London, Imperial College have published new data on breast cancer
February 26th, 2009
According to a study from London, the United Kingdom, "The purpose of this study was to determine whether primary breast cancer patients showed evidence of circulating tumour cells (CTCs) during follow-up as an alternative to monitoring disseminated bone marrow tumour cells (DTCs) by immunocytochemistry and reverse transcriptase (RT)-PCR for the detection of micrometastases. We planned to compare CTC and DTC frequency in low-risk and high-risk patients." "We identified two cohorts of primary breast cancer patients who were at low (group II, T1N0, n = 18) or high (group III, >3 nodes positive (with one exception, a patient with two positive nodes) n = 33) risk of...
Source: Women's Health Weekly (2009-02-26)
|
